Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2021

01-04-2021 | Chronic Inflammatory Bowel Disease | Original Article

Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis

Authors: Kawther Ben Abdelghani, Yosra Gzam, Alia Fazaa, Saoussen Miladi, Meriem Sellami, Leila Souabni, Selma Kassab, Selma Chekili, Leith Zakraoui, Ahmed Laater

Published in: Clinical Rheumatology | Issue 4/2021

Login to get access

Abstract

Objectives

The aim of the present study is to compare the clinical features, disease activity, and physical impairment between non-radiographic axial spondyloarthritis and ankylosing spondylitis in Tunisian patients.

Methods

This is a retrospective study conducted in a single rheumatology center in Tunisia. Patients with axial spondyloarthritis fulfilling the 2009 ASAS criteria were included. The various spondyloarthritis-related variables were compared between non-radiographic axial spondyloarthritis and ankylosing spondylitis. p Values below 0.05 were considered statistically significant.

Results

Among 200 patients with axial spondyloarthritis, 40 had non-radiographic axial spondyloarthritis and 160 had ankylosing spondylitis. The non-radiographic axial spondyloarthritis patients were more frequently female, were younger, and had shorter disease duration. Patients with non-radiographic axial spondyloarthritis experienced enthesitis more frequently compared with ankylosing spondylitis patients. Psoriasis was more frequent in non-radiographic axial spondyloarthritis group, while inflammatory bowel disease was more frequent in ankylosing spondylitis group. The C-reactive protein level and functional score were significantly higher in patients with ankylosing spondylitis compared with non-radiographic axial spondyloarthritis. Tumor necrosis factor inhibitors were offered significantly more often to the ankylosing spondylitis group. There was no statistically significant difference between the 2 groups in other spondyloarthritis parameters.

Conclusion

The non-radiographic axial spondyloarthritis is characterized mainly by a marked female prevalence, a higher enthesitis prevalence, and a better physical function.
Key points:
• Patients with nr-axSpA in Tunisia are more frequently female and have shorter disease duration compared with those with AS.
• Peripheral manifestations were similar between nr-axSpA and AS patients except for enthesitis which were more frequent within nr-axSpA patients.
• The disease activity is similar between the 2 groups of axSpA but the physical function is better within nr-axSpA patients.
Literature
1.
Sieper J, Hu X, Black CM, Grootscholten K, van den Broek RWM, Kachroo S (2017) Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 46(6):746–753CrossRef
2.
Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, Clegg DO, Colbert RA, Gensler LS, van der Heijde D, van der Horst-Bruinsma IE, Inman RD, Maksymowych WP, Mease PJ, Raychaudhuri S, Reimold A, Rudwaleit M, Sieper J, Weisman MH, Landewé RBM (2014) The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration’s comments and concerns. Arthritis Rheumatol Hoboken NJ 66(10):2649–2656CrossRef
3.
Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J (2015) Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference? J Rheumatol 42(1):31–38CrossRef
4.
Poddubnyy D, Sieper J (2014) Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment. Curr Opin Rheumatol 26(4):377–383CrossRef
5.
Zhao SS, Ermann J, Xu C, Lyu H, Tedeschi SK, Liao KP, Yoshida K, Moots RJ, Goodson NJ, Solomon DH (2019) Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States. Rheumatol Oxf Engl 58(11):2025–2030CrossRef
6.
Erol K, Gok K, Cengiz G, Kilic G, Kilic E, Ozgocmen S (2018) Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis. Acta Reumatol Port 43(1):32–39PubMed
7.
Glintborg B, Sørensen IJ, Østergaard M, Dreyer L, Mohamoud AA, Krogh NS, Hendricks O, Andersen LS, Raun JL, Kowalski MR, Danielsen L, Pelck R, Nordin H, Pedersen JK, Kraus DGA, Christensen SR, Hansen IMJ, Esbesen J, Schlemmer A, Loft AG, al Chaer N, Salomonsen L, Hetland ML (2017) Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An Observational Cohort Study from the Nationwide DANBIO Registry. J Rheumatol 44(1):59–69CrossRef
8.
Kilic E, Kilic G, Akgul O, Ozgocmen S (2015) Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study. Rheumatol Int 35(6):981–989CrossRef
9.
Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis (2013) Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 65(12):3096–3106CrossRef
10.
Hong C, Kwan YH, Leung Y-Y, Lui NL, Fong W (2019) Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore. Int J Rheum Dis 22(8):1506–1511PubMed
11.
Malaviya AN, Kalyani A, Rawat R, Gogia SB (2015) Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi. Int J Rheum Dis 18(7):736–741CrossRef
12.
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783CrossRef
13.
Mease PJ, Heijde DVD, Karki C, Palmer JB, Liu M, Pandurengan R, Park Y, Greenberg JD (2018) Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based Corrona Registry. Arthritis Care Res 70(11):1661–1670CrossRef
14.
de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL (2016) Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 18:196CrossRef
15.
López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A (2019) Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open 5(2):e001108CrossRef
16.
Wallis D, Haroon N, Ayearst R, Carty A, Inman RD (2013) Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol 40(12):2038–2041CrossRef
17.
Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J (2009) The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60(3):717–727CrossRef
18.
Gavali M, Konda K, Rajasekhar L, Devarasetti PK, Irlapati RV (2015) A comparison of clinical and laboratory profile of non-radiographic axial spondyloarthritis and ankylosing spondylitis. Indian J Rheumatol 10(3):129–132CrossRef
19.
López-Medina C, Molto A, Claudepierre P, Dougados M (2020) Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort. Ann Rheum Dis 79(2):209–216CrossRef
20.
Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Flörecke M, Bollow M, Braun J (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 64(9):1415–1422CrossRef
21.
Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474(7351):307–317CrossRef
22.
Puig L, Julià A, Marsal S (2014) The Pathogenesis and Genetics of Psoriasis. Actas Dermo-Sifiliográficas Engl Ed 105(6):535–545CrossRef
23.
24.
25.
Zouiten-Mekki L, Zaouali H, Boubaker J, Karoui S, Fekih M, Matri S, Hamzaoui S, Filali A, Chaabouni H, Hugot JP (2005) CARD15/NOD2 in a Tunisian population with Crohn’s Disease. Dig Dis Sci 50(1):130–135CrossRef
26.
Hama I, Ratbi I, Reggoug S, Elkerch F, Kharrasse G, Errabih I, Ouazzani H, Sefiani A (2012) Non-association of Crohn’s disease with NOD2 gene variants in Moroccan patients. Gene 499(1):121–123CrossRef
27.
Serbati N, Badre W, Diakite B, Nadifi S (2014) NOD2/CARD15 gene influences disease behaviour but not IBD susceptibility in a Moroccan population. Turk J Gastroenterol Off J Turk Soc Gastroenterol 25(Suppl 1):122–128
28.
Boukercha A, Mesbah-Amroun H, Bouzidi A, Saoula H, Nakkemouche M, Roy M, Hugot JP, Touil-Boukoffa C (2015) NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease. World J Gastroenterol WJG 21(25):7786–7794CrossRef
29.
Protopopov M, Poddubnyy D (2018) Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol 14(6):525–533CrossRef
30.
Dougados M, Demattei C, van den Berg R, Vo Hoang V, Thevenin F, Reijnierse M, Loeuille D, Feydy A, Claudepierre P, van der Heijde D (2016) Rate and predisposing factors for sacroiliac joint radiographic progression after a two-year follow-up period in recent-onset spondyloarthritis. Arthritis Rheumatol Hoboken NJ 68(8):1904–1913CrossRef
31.
Bubová K, Forejtová Š, Zegzulková K, Gregová M, Hušáková M, Filková M, Hořínková J, Gatterová J, Tomčík M, Szczuková L, Pavelka K, Šenolt L (2019) Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort. BMJ Open 9(4):e024713CrossRef
32.
Agafonova E, Dubinina T, Rumiantceva D, Demina A, Smirnov A, Erdes S (2019) Coxitis in early axial spondyloarthritis. Mod Rheumatol J 13:41–47CrossRef
33.
Claudepierre P, Gueguen A, Ladjouze A, Hajjaj-Hassouni N, Sellami S, Amor B et al (1995) Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol 34(12):1139–1145CrossRef
34.
El Mansouri L, Bahiri R, Abourazzak FE, Abouqal R, Hajjaj-Hassouni N (2009) Two distinct patterns of ankylosing spondylitis in Moroccan patients. Rheumatol Int 29(12):1423–1429CrossRef
35.
36.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291PubMed
37.
van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811–1818CrossRef
38.
Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574CrossRef
39.
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285PubMed
40.
Chimenti MS, Conigliaro P, Navarini L, Martina FM, Peluso G, Birra D et al (2020) Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy. Clin Exp Rheumatol 38(1):88–93PubMed
Metadata
Title
Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis
Authors
Kawther Ben Abdelghani
Yosra Gzam
Alia Fazaa
Saoussen Miladi
Meriem Sellami
Leila Souabni
Selma Kassab
Selma Chekili
Leith Zakraoui
Ahmed Laater
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05415-7

Other articles of this Issue 4/2021

Clinical Rheumatology 4/2021 Go to the issue

Correction

Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease

Brief Report

COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort

Review Article

Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs

Original Article

Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis

Original Article

The spectrum of idiopathic inflammatory myopathies in South Africa

Original Article

Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits